OmniAb (OABI) Tax Provisions (2022 - 2026)
OmniAb (OABI) posted quarterly Tax Provisions of $442000.0 for Q1 2026, up 516.98% year-over-year from $71639.1 in Q1 2025, and up 220.44% quarter-over-quarter from -$367000.0 in Q4 2025.
OmniAb (OABI) Tax Provisions (2022 - 2026) Analysis & Trends
OmniAb (OABI) has reported Tax Provisions for 5 consecutive years, with $442000.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Tax Provisions rose 516.98% year-over-year to $442000.0; the TTM figure through Mar 2026 stood at -$967000.0 (up 85.92% YoY), while the FY2025 annual figure was -$1.5 million, up 83.85% from the prior year.
- Tax Provisions rose to $442000.0 in Q1 2026 per OABI's latest filing, from -$367000.0 in the prior quarter.
- Across five years, Tax Provisions topped out at $2.8 million in Q4 2022 and bottomed at -$6.0 million in Q4 2023.
- Historically, Tax Provisions has averaged -$1.6 million across 5 years, with a median of -$1.9 million in 2022.
- Annual changes were most pronounced in 2023 — Tax Provisions slumped 312.11% — and 2026, when it jumped 516.98%.
- OmniAb's Tax Provisions stood at $2.8 million in 2022, then plunged by 312.11% to -$6.0 million in 2023, then soared by 63.93% to -$2.2 million in 2024, then soared by 82.97% to -$367000.0 in 2025, then surged by 220.44% to $442000.0 in 2026.
- Business Quant data shows OABI's Tax Provisions at $442000.0 in Q1 2026, -$367000.0 in Q4 2025, and -$1.2 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 292.00 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 230.90 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 59.00 Mn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 75.45 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 267.73 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 13.31 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 1.90 Mn |
| 10 | OmniAb | 491.42 Mn | 439.42 Mn | 12.81 Mn | -353,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -353,000.00 |
| Mar 31, 2026 | 442,000.00 |
| Dec 31, 2025 | -367,000.00 |
| Sep 30, 2025 | -1.16 Mn |
| Jun 30, 2025 | 119,000.00 |
| Mar 31, 2025 | -106,000.00 |
| Dec 31, 2024 | -2.16 Mn |
| Sep 30, 2024 | -2.71 Mn |
| Jun 30, 2024 | -1.90 Mn |
| Mar 31, 2024 | -2.62 Mn |
| Dec 31, 2023 | -5.98 Mn |
| Sep 30, 2023 | -3.30 Mn |
| Jun 30, 2023 | -3.44 Mn |
| Mar 31, 2023 | -1.03 Mn |
| Dec 31, 2022 | 2.82 Mn |
| Sep 30, 2022 | -2.31 Mn |
| Jun 30, 2022 | -2.29 Mn |
| Mar 31, 2022 | -1.94 Mn |